OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program

David W. Dodick, Catherine C. Turkel, Ronald E. Degryse, Sheena K. Aurora, Stephen D. Silberstein, Richard B. Lipton, Hans Christoph Diener, Mitchell F. Brin

Research output: Contribution to journalArticlepeer-review

583 Scopus citations

Fingerprint

Dive into the research topics of 'OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program'. Together they form a unique fingerprint.

Medicine & Life Sciences